|
| Press Releases |
|
 |
|
| Friday, August 30, 2024 |
|
|
Hua Medicine Announces 2024 Interim Results |
| Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2024 (the "Reporting Period"), and the Company's business progress for the first half of the year and business outlook. more info >> |
|
| Friday, August 25, 2023 |
|
|
Hua Medicine Announces 2023 Interim Results |
| First-in-class glucokinase activator (GKA) HuaTangNing (dorzagliatin) was approved in China in September 2022. more info >> |
|
| Monday, October 10, 2022 |
|
|
Hua Medicine's Innovative First-In-Class Glucokinase Activator (GKA) HuaTangNing Is Approved, New Type 2 Diabetes Treatment Paradigm to Begin in China |
| Hua Medicine (the "Company", HKEx Stock Code: 2552.HK) today announces that the New Drug Application (NDA) of HuaTangNing (dorzagliatin tablets, HMS5552), a first-in-class glucokinase activator (GKA) developed by the Company has been approved by the National Medical Products Administration (NMPA) of China on October 8th for two indications more info >> |
|
| Tuesday, June 7, 2022 |
|
|
Hua Medicine Announces Dorzagliatin can Restore Glucose Sensitivity and Early Phase Insulin Secretion in T2DM and GCK-MODY Patients at ADA 2022 |
| Hua Medicine (the "Company", stock code: 2552.HK) today announces that several clinical findings were presented on its global first-in-class drug, glucokinase activator (GKA) dorzagliatin, at the 82nd American Diabetes Association (ADA) Annual Scientific Sessions. more info >> |
|
| Friday, May 13, 2022 |
|
|
Hua Medicine Published Two Peer-Reviewed Papers in Nature Medicine, an International Top Medical Journal, on the Results of the Phase III Research of Dorzagliatin, a First-In-Class Investigational Diabetes Drug of Hua Medicine |
| Hua Medicine (the "Company", stock code on the main board of the Hong Kong Stock Exchange: 2552.HK) today announces that, two peer-reviewed papers on the Phase III clinical trial results of dorzagliatin more info >> |
|
| Thursday, March 17, 2022 |
|
|
Hua Medicine Announces 2021 Annual Results |
| Hua Medicine (the "Company", Stock Code: 2552.HK) today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2021 (the "Reporting Period"). The Reporting Period witnessed significant milestones in the commercialization process of dorzagliatin. more info >> |
|
| Sunday, September 26, 2021 |
|
|
Researchers Present Key Research Results on Diabetes Remission of Dorzagliatin |
| Hua Medicine (2552.HK) announced that at the 6th China BioMed Innovation & Investment Conference (CBIIC), Professor Jianhua MA, Director, Department of Endocrinology, Nanjing First Hospital, Standing Member of the Chinese Diabetes Society, as one of the principal researchers presented the results from a clinical study called DREAM, which showed that dorzagliatin, a glucokinase activator and a first-in-class investigational drug of Hua Medicine, may make progress in diabetes remission. more info >> |
|
| Wednesday, September 15, 2021 |
|
|
Hua and Sinopharm Announced Supply Chain Strategic Cooperation |
| On September 13, 2021, Hua Medicine (Shanghai) Ltd. (the "Hua Medicine", Stock Code: 2552.HK) has signed a supply chain strategic cooperation agreement with Sinopharm Group Co., Ltd. (the "Sinopharm", Stock Code: 1099). more info >> |
|
| Thursday, August 19, 2021 |
|
|
Hua Medicine Announces 2021 Interim Results |
| Hua Medicine (the "Company", Stock Code: 2552.HK), today announces the consolidated results of the Company and its subsidiaries for the six months ended June 30, 2021 (the "Reporting Period"). more info >> |
|
| Friday, April 23, 2021 |
|
|
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally |
| Hua Medicine (the "Company", Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was accepted by the China National Medical Products Administration (NMPA). more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Concord New Energy Signs MOU with Bain Capital-Backed Bridge Data Centre
Mar 3, 2026 15:27 HKT/SGT
|
|
|
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
Mar 3, 2026 12:14 HKT/SGT
|
|
|
Affiliate of Pacific Avenue Capital Partners to Acquire Care.com from IAC
Mar 3, 2026 08:00 HKT/SGT
|
|
|
Lessn exceeds $100 million turnover on its payments orchestration platform
Mar 3, 2026 06:00 HKT/SGT
|
|
|
Graphene Manufacturing Group Ltd. Approves AU$1.4 Million Deployment: The Remaining Capital Needed for a Second Generation
Mar 3, 2026 04:59 HKT/SGT
|
|
|
Doubleview Gold Corp. Announces Positive Preliminary Economic Assessment for the Hat Project; Robust Base-Case Economics with Strategic Scandium Upside
Mar 3, 2026 00:59 HKT/SGT
|
|
|
With Step-Out Drilling Continuing, Radisson Demonstrates Meaningful Resource Growth at O'Brien with an Updated Mineral Resource Estimate
Mar 2, 2026 19:59 HKT/SGT
|
|
|
Lincotrade Unveils Freehold Residential Project, The Shang Residence, in Kuala Lumpur, Malaysia
Mar 2, 2026 19:54 HKT/SGT
|
|
|
Focus Graphite Officially Commences Government-Supported Thermal Purification Project to Establish Dual-Use Graphite Production in Canada
Mar 2, 2026 18:29 HKT/SGT
|
|
|
The HK International Diamond, Gem & Pearl Show opens today; The HK International Jewellery Show starts Wednesday
Mar 2, 2026 18:20 HKT/SGT
|
|
|
MHI and SoftBank Corp. Collaborate to Adapt AI-RAN Network Architecture for Edge Data Centers
Mar 2, 2026 19:13 JST
|
|
|
Exito Media Concepts Announces the 32nd Edition of the Manufacturing IT Summit - Thailand 2026
Mar 2, 2026 17:00 HKT/SGT
|
|
|
DOCOMO and NEC Launch Japan's First Commercial 5G Core on AWS, Built with World's First AI-automated Network Construction Technology
Mar 2, 2026 16:34 JST
|
|
|
AI Safety Asia Advances Crisis Diplomacy and Evidence-Based AI Governance at India AI Impact Summit 2026
Mar 2, 2026 15:15 HKT/SGT
|
|
|
Fujitsu supports sustainable growth for retailers with data and AI through Uvance for Retail
Mar 2, 2026 11:55 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
